The incidence of hypoglycemia between SGLT2-Is (7.8%) and placebo (11.1%), demonstrated no statistically significant difference (OR = 0.98; 95% CI 0.83–1.15). The gene discussed is SLC5A2; the disease is Hypoglycemia.